Skip to main content

Table 2 Univariate and multivariate associations with ΔFEV1 ≥ 400 mL in ACO patients

From: The value of bronchodilator response in FEV1 and FeNO for differentiating between chronic respiratory diseases: an observational study

Variable

Univariate analysis HR (95% Cl)

P-value

Multivariate analysis HR (95% Cl)

P-value

Age (year)

0.97 (0.92–1.02)

P = 0.187

  

Sex (female vs. male)

1.40 (0.29–6.81)

P = 0.679

  

BMI (kg/m2)

0.96 (0.81–1.13)

P = 0.598

  

Smoking index (pack-year)

1.00 (0.97–1.02)

P = 0.765

  

FEV1 (mL)

1.71 (0.77–3.78)

P = 0.188

  

Predicted FEV1 (%)

1.01 (0.99–1.03)

P = 0.421

  

FVC (mL)

1.97 (1.04–3.71)

P = 0.037

2.71 (1.31–5.63)

P = 0.007

Predicted FVC (%)

1.02 (0.99–1.04)

P = 0.132

  

FEV1/FVC (%)

1.00 (0.96–1.05)

P = 0.982

  

FeNO (ppb)

1.00 (0.99–1.02)

P = 0.519

  

Total eosinophils (/μL)

1.00 (0.99–1.00)

P = 0.543

  

Eosinophils (%)

0.99 (0.72–1.35)

P = 0.937

0.06 (0.01–0.55)

P = 0.013

ICS/LABA/LAMA (yes vs. no)

0.12 (0.01–0.94)

P = 0.044

  
  1. HR, relative risk; 95% CI, 95% confidence interval; BMI, body mass index; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; FeNO, fractional exhaled nitric oxide; ICS, inhaled corticosteroids; LABA, long-acting beta-2 agonist; LAMA, long-acting muscarinic antagonist